Live Micron Technology Inc Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow RENALYTIX PLC

Get SEC filing alerts via email and in your feed for RENALYTIX PLC

RENX RNLX RTNXF RNLXY RENXF

RENALYTIX PLC

About RENALYTIX PLC

Renalytix plc is a healthcare technology company focused on transforming kidney disease management through its innovative KidneyIntelX platform. Its flagship product, kidneyintelX.dkd, is an FDA-authorized prognostic test that assesses the risk of kidney function decline in adults with diabetes. Targeting a market of approximately 14 million U.S. patients, Renalytix aims to improve patient outcomes and reduce healthcare costs through early intervention and comprehensive insurance coverage initiatives.
This description was generated via AI from an annual report. Updated 9 months ago.
renalytix.com

Latest SEC Filings from RENALYTIX PLC

1
1
RENALYTIX PLC Renalytix plc Reports 14% Revenue Growth, Reduced Losses in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments